Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, March 15 '25)

Image
By G.M.

 


    Am J Obstet Gynecol

  1. TAN YY, Loy EXH, Tan WZ, Tay AT, et al
    Long COVID-19 in pregnancy: increased risk but modest incidence following mild Omicron infection in a boosted obstetric cohort during endemicity.
    Am J Obstet Gynecol. 2025 Mar 10:S0002-9378(25)00147.
    PubMed         Abstract available


    BMJ

  2. IACOBUCCI G
    Covid-19: Gove tried to "circumvent" regulations to buy Dyson ventilators, inquiry hears.
    BMJ. 2025;388:r502.
    PubMed        


    Clin Infect Dis

  3. BARTOLETTI M, Mozaffari E, Amin AN, Doi Y, et al
    A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 infection in hospitalized patients: have the guidelines evolved with the evidence?
    Clin Infect Dis. 2025 Mar 11:ciaf111. doi: 10.1093.
    PubMed         Abstract available

  4. COX SN, Roychoudhury P, Frivold C, Acker Z, et al
    Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023.
    Clin Infect Dis. 2025 Mar 14:ciaf048. doi: 10.1093.
    PubMed         Abstract available

  5. KELLY JD, Hoggatt KJ, Lo NC, Leonard S, et al
    Annual variant-targeted vaccination to prevent severe COVID-19 disease in cohorts with vaccine-derived and hybrid immunity.
    Clin Infect Dis. 2025 Mar 14:ciaf124. doi: 10.1093.
    PubMed         Abstract available

  6. ROCKSTROH JK, Paredes R, Cahn P, Molina JM, et al
    Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trial.
    Clin Infect Dis. 2025 Mar 13:ciaf077. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  7. LI Z, Wang Z, Wang X, Chen S, et al
    Global containment policy duration and long-term epidemic progression: a target trial emulation using COVID-19 data from 2020 to 2022.
    Int J Infect Dis. 2025 Mar 5:107871. doi: 10.1016/j.ijid.2025.107871.
    PubMed         Abstract available

  8. MADEWELL ZJ, Wong JM, Thayer MB, Rivera-Amill V, et al
    Population-level respiratory virus-virus interactions, Puerto Rico, 2013-2023.
    Int J Infect Dis. 2025 Mar 11:107878. doi: 10.1016/j.ijid.2025.107878.
    PubMed         Abstract available


    J Infect

  9. WARD T, Paton RS, Overton CE, Mellor J, et al
    Understanding the Effectiveness of the Comirnaty Monovalent and Bivalent Vaccines During the Winter Coronavirus (COVID-19) Infection Survey.
    J Infect. 2025 Mar 5:106461. doi: 10.1016/j.jinf.2025.106461.
    PubMed         Abstract available


    J Med Virol

  10. AZANZA JR, Gonzalez Del Castillo JM, Ferrando R, Molero JM, et al
    Cost-Effectiveness of Nirmatrelvir/Ritonavir in COVID-19 Patients at High-Risk for Progression in Spain.
    J Med Virol. 2025;97:e70288.
    PubMed         Abstract available

  11. LIU S, Liu P, Lu Q, Shen Y, et al
    The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS-CoV-2 Omicron Variants.
    J Med Virol. 2025;97:e70242.
    PubMed         Abstract available

  12. GARCIA-VIDAL C, Teijon-Lumbreras C, Aiello TF, Chumbita M, et al
    COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based Approach.
    J Med Virol. 2025;97:e70276.
    PubMed         Abstract available


    JAMA

  13. LAURING AS, Edson C, Surie D, Dawood FS, et al
    Genomic Characterization of RSV in the US by Vaccination Status.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.1225.
    PubMed        


    Lancet

  14. SINGH B, Lipunga GD, Thangavelu P, Dhar S, et al
    A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi: an international multicentre intervention study.
    Lancet. 2025 Mar 10:S0140-6736(25)00263-6. doi: 10.1016/S0140-6736(25)00263.
    PubMed         Abstract available

  15. WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
    Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038.
    PubMed         Abstract available


    Nature

  16. GOETZKE CC, Massoud M, Frischbutter S, Guerra GM, et al
    TGFbeta links EBV to multisystem inflammatory syndrome in children.
    Nature. 2025 Mar 12. doi: 10.1038/s41586-025-08697.
    PubMed         Abstract available

  17. CALLAWAY E
    Four ways COVID changed virology: lessons from the most sequenced virus of all time.
    Nature. 2025;639:293-295.
    PubMed        


  18. Immune molecule links COVID?19 with severe inflammatory disorder in children.
    Nature. 2025 Mar 12. doi: 10.1038/d41586-025-00735.
    PubMed        


    Pol J Radiol

  19. HAJSADEGHI S, Kasaei M, Pouraliakbar H, Jamalkhani S, et al
    Comparing myocardial injury patterns and outcomes in cardiac magnetic resonance imaging between COVID-19- and non-COVID-19-related myocarditis.
    Pol J Radiol. 2025;90:e36-e45.
    PubMed         Abstract available


    Science

  20. WADMAN M
    No sign that vaccine advisers are beholden to industry.
    Science. 2025;387:1131-1132.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

Stability of #influenza viruses in the #milk of #cows and #sheep

By G.M.
Abstract In late 2023, H5N1 high pathogenicity avian influenza (HPAIV) started circulating in dairy cattle in the USA . High viral titres were detected in milk from infected cows , raising concerns about onwards human infections . Although pasteurisation was shown to effectively inactivate influenza viruses in milk, unpasteurised milk still poses a risk of infection, both from occupational exposure in dairies and from the consumption of raw milk. We therefore assessed how long influenza viruses could remain infectious for in milk without heat inactivation. We examined the stability of a panel of influenza viruses in milk , including a contemporary H5N1 HPAIV and a variety of other influenza A and D viruses. We incubated viruses in cows' milk under laboratory conditions : at room temperature to simulate exposure in dairies and at 4°C to simulate exposure to refrigerated raw milk. Following an isolated report of H5N1 viral RNA being detected in milk from a sheep in the UK , we also c...
Post a Comment
Read more »

#Evidence of #Viremia in Dairy #Cows Naturally Infected with #Influenza A {#H5N1} Virus, #California, #USA

By G.M.
Abstract We confirmed influenza A virus (IAV) by PCR in serum from 18 cows on 3 affected dairy farms in California, USA . Our findings indicate the presence of viremia and might help explain IAV transmission dynamics and shedding patterns in cows. An understanding of those dynamics could enable development of IAV mitigation strategies. Source: US Centers for Disease Control and Prevention,  https://wwwnc.cdc.gov/eid/article/31/7/25-0134_article ____
Post a Comment
Read more »